Ishita Drugs And Industries Limited, a active public limited company, was established on 05 February 1992 in Ahmedabad, Gujarat, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: L24231GJ1992PLC017054. Registered under ROC Roc Ahmedabad. it is listed on BSE: 524400. It has an authorized capital of ₹6.00 Cr and a paid-up capital of ₹2.99 Cr.
It upholds a compliant status. In 2024, it reported revenue of ₹15.47 Cr and a net worth of ₹9.92 Cr. Employing 7 professional, Its leadership includes Dhwani Jaspalsinh Solanki (Director), Jagdishprasad Agrawal Gokulchand (Managing Director), Arvind Vilasrao Sapkal (Director). Past directors included Dhwani Jaspalsinh Solanki, Shyamkumar Omprakash Agarwal, Shah Niharika Rajeshbhai. It holds ₹5.95 Cr open charges and no settled loans. Its latest AGM occurred on 29 September 2025, with the balance sheet filed on 31 March 2025. It is based at Survey No 179/1, Vasna-Iyava, Taluka Sanand, Ahmedabad, Gujarat, 382210.
L24231GJ1992PLC017054
017054
05 February 1992
₹6.00 Cr
₹2.99 Cr
Roc Ahmedabad
Listed (BSE: 524400)
Active
Explore comprehensive insights into Ishita Drugs And Industries Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Dhwani Jaspalsinh Solanki | Director | 13 Aug 2024 | Current |
| Jagdishprasad Agrawal Gokulchand | Managing Director | 05 Feb 1992 | Current |
| Arvind Vilasrao Sapkal | Director | 12 Nov 2019 | Current |
| Abha Agrawal Jagdishprasad | Director | 05 Feb 1992 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 29 Sep 2024 | Past |
| Pramod Abcsdd | Director | 12 Nov 2019 | Past |
| Pramod Abcsdd | Company Secretary | - | Past |
| Pramod Abcsdd | Additional Director | 30 Sep 2020 | Past |
| Pramod Abcsdd | Director | 30 Jun 2020 | Past |
| Pramod Abcsdd | Director | 12 Nov 2024 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Ishita Drugs And Industries Limited, for the financial year ended 2024, experienced significant growth in revenue, with a 26.03% increase. The company also saw a substantial improvement in profitability, with a 29.63% increase in profit. The company's net worth moved up by a moderate rise of 8.16%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2024, Ishita Drugs And Industries had a promoter holding of 49.42% and a public holding of 50.58%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹59,500,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 23 Oct 2024 | Others | ₹4.20 Cr | Open |
| 10 May 2007 | Corporation Bank | ₹1.75 Cr | Open |
Explore comprehensive loan charge details -
Ishita Drugs And Industries has a workforce of 7 employees as of Feb 28, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Ishita Drugs And Industries, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ishita Drugs And Industries's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Ishita Drugs And Industries Limited last Annual general meeting of members was held on 29 Sep 2025 as per latest MCA records. was completed.
Ishita Drugs And Industries Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Ahmedabad. was recorded as a recent event.
A charge with Others of Rs. 4.20 Cr registered on 23 Oct 2024 with Charge ID 101002177 was modified on 11 Feb 2025. was recorded as a recent event.
Progress on A charge with Others amounted to Rs. 4.20 Cr with Charge ID 101002177 was registered on 23 Oct 2024. was documented.
The activity Dhwani Jaspalsinh Solanki was appointed as a Director was appointed as a Director on 13 Aug 2024 & has been associated with this company since 1 year 5 months . was completed.
The activity Srushti Pandya was appointed as a Company Secretary was appointed as a Company Secretary on 04 Feb 2021 & has been associated with this company since 4 years 11 months . was completed.
The CIN of Ishita Drugs And Industries Limited is L24231GJ1992PLC017054.
Ishita Drugs And Industries Limited is headquartered at Survey No 179/1, Vasna-Iyava, Taluka Sanand, Ahmedabad, Gujarat, 382210.
Ishita Drugs And Industries Limited was incorporated on 05 February 1992.
The current directors of Ishita Drugs And Industries Limited are
The primary industry of Ishita Drugs And Industries Limited is Manufacturing.
Ishita Drugs And Industries Limited is listed. It is listed on BSE: 524400.
The authorized capital of Ishita Drugs And Industries Limited is ₹6.00 Cr, and the paid-up capital is ₹2.99 Cr.
The compliance status of Ishita Drugs And Industries Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX